Funds advised by local private equity firm Permira, supported a co-investor, a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), have entered into a partnership with Kedrion’s existing shareholders (the Marcucci family and FSI) to jointly acquire and combine Kedrion and BPL.
BPL, headquartered outside London, UK, operates a targeted portfolio of successful rare disease products and is one of the fastest growing players in the plasma industry.
As a result of this transaction, the Permira funds will own a controlling stake in the combined business, which generates approximately EUR1.1 billion in annual revenues and employs in excess of 4,000 people worldwide.
Read more/Source: Private Equity Wire
